Skip to main content

Table 4 Comparison of baseline demographics at time of diagnosis between patients on active surveillance (AS) and patients who met active surveillance criteria but chose upfront radical prostatectomy (RP)

From: Impact of bilateral biopsy-detected prostate cancer on an active surveillance population

Variable

Active Surveillance

Radical Prostatectomy

 

Median (IQR)

Median (IQR)

p-value

Age (years)

61 (57–66)

58 (54–62)

< 0.01*

PSA (ng/ml)

5.08 (4.2–7)

5 (4–6.6)

0.39

BMI (kg/m2)

27.52 (25.63–31.74)

28.98 (25.78–32)

0.27

Prostate vol (mL)

42 (32–57)

40 (31–53)

0.39

PSA density

0.13 (0.09–0.16)

0.12 (0.09–0.18)

0.58

  1. *All patients Gleason 6 at diagnosis
  2. Prostate Specific Antigen (PSA), Body Max Index (BMI)